CD35 Recombinant Rabbit Monoclonal Antibody [JE54-31] (ET7111-05)

UNIPROT #

P17927

PROTEIN NAME

CD35

SYNONYMS

C3 binding protein antibody;C3b/C4b receptor antibody;C3BR antibody;C4BR antibody;CD 35 antibody;CD35 antibody;CD35 antigen antibody;complement component (3b/4b) receptor 1 (Knops blood group) antibody;complement component (3b/4b) receptor 1 including Knops blood group system antibody;Complement component receptor 1 antibody;Complement receptor 1 antibody;Complement receptor type 1 antibody;CR 1 antibody;CR1 antibody;CR1_HUMAN antibody;KN antibody;Knops blood group antigen antibody

SEQUENCE SIMILARITIES

Belongs to the receptors of complement activation (RCA) family.

TISSUE SPECIFICITY

Present on erythrocytes, a subset of T cells, mature B cells, follicular dendritic cells, monocytes and granulocytes.

SUBCELLULAR LOCATION

Membrane.

FUNCTION

Complement receptor type 1 (CR1) also known as C3b/C4b receptor or CD35 (cluster of differentiation 35) is a protein that in humans is encoded by the CR1 gene.[3][4] This gene is a member of the regulators of complement activation (RCA) family and is located in the 'cluster RCA' region of chromosome 1. The gene encodes a monomeric single-pass type I membrane glycoprotein found on erythrocytes, leukocytes, glomerular podocytes, hyalocytes, and splenic follicular dendritic cells. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Decreases in expression of this protein and/or mutations in its gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus and sarcoidosis. Mutations in this gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. Alternate allele-specific splice variants, encoding different isoforms, have been characterized. Additional allele specific isoforms, including a secreted form, have been described but have not been fully characterized.In primates, CR1 serves as the main system for processing and clearance of complement opsonized immune complexes. It has been shown that CR1 can act as a negative regulator of the complement cascade, mediate immune adherence and phagocytosis and inhibit both the classic and alternative pathways. The number of CR1 molecules decreases with aging of erythrocytes in normal individuals and is also decreased in pathological conditions such as systemic lupus erythematosus (SLE), HIV infection, some haemolytic anaemias and other conditions featuring immune complexes.[5] In mice, CR1 is an alternatively spliced variant of the complement receptor 2 (CR2) gene.Certain alleles of this gene have been statistically associated with an increased risk of developing late-onset Alzheimer's disease.